Southlake, TX based OncoNano Medicine is harnessing nanotechnology to identify and target cancer - a lead program hits the STING pathway
CFO Matthew Head describes the company's ON-BOARD platform and how they are not only developing therapeutics, but also an imaging product that has breakthrough designation.
Brought to you by